Skip to main content

Table 4 Additional resilient ligand-PKM2 interactions that differed from Moscatilin

From: Docking and ADMET studies for investigating the anticancer potency of Moscatilin on APC10/DOC1 and PKM2 against five clinical drugs

Ligand

Target protein (PDB ID)

Mode of interaction

Residue

Amino acid

Group involved

Interacting ligand atom positions

Colchicine

PKM2 (IZJH)

Water bridge

42A

Arginine

Protein donor involved

4017

69A

Asparagine

4016

Paclitaxel

Ï€-cation interaction

260A

Lysine

Aromatic

4006, 4007, 4034, 4035, 4041, 4043

Shikonin

Water bridge

69A

Asparagine

Protein donor involved

3907

Ï€-stacking

469A

Phenylalanine

T-type

4005,4006,4007, 4008, 4009, 4010, 4011, 4012, 4013, 4014